ESTA — Establishment Labs Holdings Inc. stock price, charts and financials

Latest market price

94.61

+1.81+1.95%

Overview Short InterestFilings

ESTAQT64Establishment Labs Holdings Inc.·NASDAQ

Overview Short InterestFilings

94.61+1.95%

Loading chart...

Screen all →

TMDX-0.98%$80.75 UFPT+25.16%$334.84 AXGN+0.50%$45.96 BFLY+7.18%$8.81 HAE-1.62%$85.38 NVCR+6.20%$16.27 IRTC+1.98%$127.13 INSP+22.83%$64.14

Snapshot

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	-	Shs Outstand	29.43M	Perf Week	2.95%

Market Cap	2.78B	Forward P/E	-	EPS next Y	0.02	Insider Trans	-2.11%	Shs Float	26.95M	Perf Month	3.33%

Enterprise Value	2.98B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	16.64%	Perf Quarter	34.70%

Income	-44.00M	P/S	12.11	EPS this Y	22.52%	Inst Trans	-	Short Ratio	7.35	Perf Half Y	32.79%

Sales	230.00M	P/B	185.62	EPS next Y	101.41%	ROA	-12.46%	Short Interest	4.48M	Perf YTD	29.82%

Book/sh	0.51	P/C	40.95	EPS next 5Y	-	ROE	-225.86%	52W High	97.59 -3.05%	Perf Year	128.86%

Cash/sh	2.31	P/FCF	-	EPS past 3/5Y	-	ROIC	-8.67%	52W Low	33.35 183.69%	Perf 3Y	30.01%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.21% 19.94%	Gross Margin	70.06%	Volatility	3.59% 3.90%	Perf 5Y	30.71%

Dividend TTM	-	EV/Sales	12.95	EPS Y/Y TTM	50.67%	Oper. Margin	-12.45%	ATR (14)	3.73	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	1.91	Sales Y/Y TTM	38.55%	Profit Margin	-19.05%	RSI (14)	63.46	Recom	2.14

Dividend Gr. 3/5Y	-	Current Ratio	2.96	EPS Q/Q	42.86%	SMA20	3.37%	Beta	1.08	Target Price	105.00

Payout	0.00%	Debt/Eq	10.96	Sales Q/Q	46.34%	SMA50	11.06%	Rel Volume	0.77	Prev Close	92.80

Employees	1,004	LT Debt/Eq	10.46	Earnings	Aug 06	SMA200	33.05%	Avg Volume	611.93K	Price	94.61

IPO Date	Jul 19, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-12.69% 4.32%	Net Debt/EBITDA	-13.62	Volume	468,259	Change	1.95%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-15-26	Reiterated	Mizuho	Outperform	$70 → $105
Dec-31-25	Reiterated	BTIG	Buy	$81 → $86
Dec-17-25	Reiterated	Canaccord Genuity	Buy	$85
Dec-10-25	Reiterated	Needham	Buy	$70 → $84
Nov-14-25	Reiterated	BTIG	Buy	$70 → $81
Nov-06-25	Reiterated	Needham	Buy	$70
Nov-05-25	Reiterated	BTIG	Buy	$110 → $70
May-14-25	Upgrade	Needham	Hold → Buy
Aug-22-24	Reiterated	Citigroup	Neutral	$45
Jun-06-24	Reiterated	Mizuho	Buy	$65 → $70

Latest News

Jul-31-26

Jul-31-2608:35AM

Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial StockBenzinga

Jul-23-26

Jul-23-2608:00AM

Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6businesswire.com

Jul-21-26

Jul-21-2603:14AM

AlTi Global Inc. Makes New Investment in Establishment Labs Holdings Inc. $ESTAdefenseworld.net

Jul-15-26

Jul-15-2602:26PM

Mizuho Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $105Benzinga

Jul-08-26

Jul-08-2611:32AM

Citigroup Maintains Neutral on Establishment Labs Hldgs, Raises Price Target to $92Benzinga

Jul-07-26

Jul-07-2611:30AM

Establishment Labs Holdings (NASDAQ:ESTA) Meets Minervini Trend Template and High Growth Momentum CriteriaChartMill

Jul-05-26

Jul-05-2605:18PM

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.fool.com

Jun-29-26

Jun-29-2608:00AM

Establishment Labs® Appoints Taylor Harris to Board of Directorsbusinesswire.com

Jun-25-26

Jun-25-2608:05AM

Establishment Labs Set To Join Russell 2000 Index, Effective June 29Benzinga

Company

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	230	211	166	165	162	127	85	90	61
Cost of Goods Sold Incl. D&A	69	65	57	58	55	41	32	35	25
Gross Profit	161	146	110	107	107	85	53	55	36
Selling, General and Administrative Excl. Other	169	165	140	146	126	92	67	71	47
Research and Development	20	20	20	26	20	18	14	15	13
Other Operating Expense	0	0	0	0	0	1	-1	0	0
Operating Income	-29	-39	-50	-65	-40	-25	-28	-31	-24
Interest Expense	26	25	21	15	12	9	9	9	9
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	4	6	-14	2	-21	-6	-1	2	12
Net Income Before Taxes	-52	-58	-85	-79	-73	-40	-38	-38	-21
Income Taxes	-8	-7	0	0	2	1	0	1	0
Consolidated Net Income	-44	-51	-85	-79	-75	-41	-38	-38	-21
Net Income From Continuing Operations	-44	-51	-85	-79	-75	-41	-38	-38	-21
Net Income	-44	-51	-85	-79	-75	-41	-38	-38	-21
EPS (Recurring)	-1.48	-1.72	-3.00	-3.07	-3.08	-1.72	-1.63	-1.86	-1.22
EPS (Basic, Before Extraordinaries)	-1.48	-1.72	-3.00	-3.07	-3.08	-1.72	-1.63	-1.86	-1.22
EPS (Diluted)	-1.48	-1.72	-3.00	-3.07	-3.08	-1.72	-1.63	-1.86	-1.22
EBITDA	-14	-22	-56	-58	-57	-27	-25	-26	-9
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	12.34	10.36	7.77	4.08	9.73	12.77	10.18	6.45	7.64
Gross Margin	70.00	69.19	66.27	64.85	66.05	66.93	62.35	61.11	59.02
Operating Margin	-12.61	-18.48	-30.12	-39.39	-24.69	-19.69	-32.94	-34.44	-39.34
Net Margin	-19.13	-24.17	-51.20	-47.88	-46.30	-32.28	-44.71	-42.22	-34.43
Shares Outstanding	30	30	28	26	24	24	23	21	17
Market Capitalization	2,838	2,186	1,290	673	1,576	1,622	866	581	466
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JW Asset Management, LLC	other: See footnote 3	May 28 '26	Sale	72.89	65,100	4,745,139	2,890,582	May 28
JW Asset Management, LLC	other: See footnote 3	May 27 '26	Sale	72.50	113	8,193	2,955,682	May 28
JW Asset Management, LLC	other: See footnote 3	May 26 '26	Sale	74.39	25,320	1,883,555	2,955,795	May 28
JW Asset Management, LLC	10% Owner	May 21 '26	Sale	71.40	16,999	1,213,729	2,981,115	May 22
JW Asset Management, LLC	10% Owner	May 20 '26	Sale	70.56	3,580	252,605	2,998,114	May 22
JW Asset Management, LLC	10% Owner	May 06 '26	Sale	75.63	60,000	4,537,500	3,001,694	May 08
Chacon Quiros Juan Jose	Director	May 06 '26	Sale	75.42	105,000	7,918,872	927,504	May 08
Chacon Quiros Juan Jose	Director	May 04 '26	Sale	70.48	7,751	546,308	1,032,504	May 04
Chacon Quiros Juan Jose	Director	May 01 '26	Sale	70.78	67,249	4,759,569	1,040,255	May 04
Chacon Quiros Juan Jose	Director	Apr 27 '26	Sale	66.26	2,180	144,439	1,107,504	Apr 27
Chacon Quiros Juan Jose	Director	Apr 24 '26	Sale	65.78	30,178	1,984,969	1,109,684	Apr 27
Chacon Quiros Juan Jose	Director	Apr 23 '26	Sale	65.43	42,642	2,790,070	1,139,862	Apr 27
Chacon Quiros Juan Jose	Director	Apr 14 '26	Sale	65.23	37,500	2,446,050	1,182,504	Apr 16
SCHUTTER EDWARD J	Director	Apr 02 '26	Option Exercise	4.11	36,780	151,166	175,382	Apr 02
Chacon Quiros Juan Jose	Director	Mar 25 '26	Sale	60.08	3,575	214,768	1,220,004	Mar 27

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.